Tumor Lysis Syndrome [syndrom nádorového rozpadu]
- Terms
-
syndrom lýzy nádoru
syndrom lýzy tumoru
syndrom nádorové lýzy
-
Tumour Lysis Syndrome
A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
- Annotation
- lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol (not /chem ind) + anticancer drug /adv eff (IM) + required neopl coords /drug ther (IM or NIM) if pertinent
- DUI
- D015275 MeSH Browser
- CUI
- M0023515
- Previous indexing
- Antineoplastic Agents, Combined/adverse effects/therapeutic use (1980-1988); Antineoplastic Agents/therapeutic use (1984-1988); Burkitt's Lymphoma/complications (1980-1988)
- History note
- 89
- Public note
- 89
Allowable subheadings
- BL
- blood 2
- CF
- cerebrospinal fluid
- CL
- classification 3
- CO
- complications 5
- CN
- congenital
- DI
- diagnosis 11
- DG
- diagnostic imaging 1
- DH
- diet therapy
- DT
- drug therapy 7
- EC
- economics
- EM
- embryology
- EN
- enzymology
- EP
- epidemiology 1
- EH
- ethnology
- ET
- etiology 9
- GE
- genetics
- HI
- history
- IM
- immunology
- ME
- metabolism 3
- MI
- microbiology
- MO
- mortality
- NU
- nursing
- PS
- parasitology
- PA
- pathology 2
- PP
- physiopathology 6
- PC
- prevention & control 13
- PX
- psychology
- RT
- radiotherapy
- RH
- rehabilitation
- SU
- surgery
- TH
- therapy 17
- UR
- urine
- VE
- veterinary
- VI
- virology